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Abstract—A catalyst-free highly efficient synthesis of 3(5)-amino-5(3)-(het)aryl-1,2,4-triazoles in aqueous medium was performed using 
conventional heating and microwave irradiation. The tautomerism in the products was investigated using NMR spectroscopy and X-ray 
crystallography. The effects of the substitution, temperature, solvents and concentration on the tautomerism were studied. The triazoles 
were found to exist in 1H-forms, the 4H-form was not observed either in solid state or in solution. In general, 5-amino-1,2,4-triazoles were 
electronically preferred in the tautomeric equilibrium, but some exceptions from the established relationship were also identified. © 2011 
Elsevier Science. All rights reserved 
——— 
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1,2,4-Triazoles represent a class of heterocyclic compounds 
of significant importance in agriculture and medicine.1 
They are also used in metalloorganic chemistry as 
polyfunctional ligands.2 Among 1,2,4-triazoles, 3(5)-
amino-1,2,4-triazoles have been recognized, primarily, as 
valuable synthons for the construction of more complex 
structures, particularly biologically active fused 
heterocycles (e.g. 1,2,4-triazolo[1,5-a]pyrimidines3 and 
1,2,4-triazolo[1,5-a][1,3,5]triazines4).  
The most straightforward and commonly used method for 
the preparation of 3(5)-amino-1,2,4-triazoles 2 involves the 
cyclocondensation of amidoguanidines 1 (Scheme 1). 
However, the use of a high temperature (often above the 
melting point)5 or the presence of a strong base5e in the 
reaction complicated the workup and led to decreased 
yields of the products. Herein we describe a method which 
avoids these drawbacks and leads to 3(5)-amino-1,2,4-




Scheme 1.  
Tautomerism in five-membered heterocyclic systems is an 
intriguing phenomenon, which has been well recognized 
for a long time.6 A knowledge of the tautomeric 
preferences and the factors affecting the equilibrium is 
essential for understanding the reactivity of compounds in 
chemical processes and their effects on biological systems. 
Due to annular prototropic tautomerism, 1,2,4-triazoles, 
particularly amino-1,2,4-triazoles without substituents on 
the ring nitrogen atoms, a priori can exist in three forms, 
viz 3-amino-1H-1,2,4-triazoles (A), 5-amino-1H-1,2,4-
triazoles (B) and 3-amino-4H-1,2,4-triazoles (C) (Scheme 
2). A number of theoretical reports7 have appeared in the 
area of tautomerism in amino-1,2,4-triazoles, but 
experimental studies have often ignored this phenomenon 
and some data were misinterpreted. In this Letter, we 
present a study on the tautomerism in 3(5)-amino-5(3)-
(het)aryl-1,2,4-triazoles using NMR spectroscopy and X-
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Table 1. Synthesis of triazoles 2a-j via cyclocondensation of 










mp, °C (lit) 
2a Ph 4 20 97 186-187 
(186-187)5e 
2b 4-MeC6H4 4 20 98 209  
(207)8a 
2c 4-MeOC6H4 8 40 96 226  
(224-226)5e 
2d 4-FC6H4 3 20 95 188-189  
 
2e 4-ClC6H4 6 60
b 94 229-230 
(227-229)5e 
2f 2-furyl 6 20 95 211-212 
(204-206)8b 
2g 2-thienyl 8 30 97 214 
 
2h 2-pyridyl 4 20 92 220-221 
(217)8c 
2i 3-pyridyl 6 20 98 224-225 
(223)8c 
2j 4-pyridyl 6 20 98 272-274 
(276-278)5d 
aVolume of water per 1 g of 1. 
b40% ethanol was used as solvent. 
Green chemistry, which is an essential part of process 
development in modern chemistry, has also begun to 
influence medicinal chemistry significantly.9 The design of 
an environmentally friendly synthesis includes elaboration 
of methods able to avoid or minimize the formation of 
byproducts, the selection of a safe solvent and effective use 
of energy. Water is considered to be the best solvent for 
sustainable chemistry.10 We found that 
(het)arylamidoguanidines (1), upon heating in water, 
underwent quantitative cyclocondensation with elimination 
of a water molecule affording 3(5)-amino-5(3)-(het)aryl-
1,2,4-triazoles (2) (Table 1). 11 The reaction provided the 
products in excellent purity and did not require the 
presence of base or catalyst. The solubility of the starting 
(het)arylamidoguanidines 1 was found to be a limiting 
factor of the reaction and increasing the volume of water or 
using a co-solvent (ethanol) were required for some less 
soluble amidoguanidines 1. However, when ethanol was 
used as the sole solvent instead of water, the conversion of 
1a into 3(5)-amino-5(3)-phenyl-1,2,4-triazole (2a) did not 
proceed to the completion even after 3 days of heating 
under reflux.  
Microwave irradiation is an alternative source of energy, 
which allows highly effective use of the heat produced, 
reducing reaction times and often improving yields. 
Microwave-assisted syntheses have found extensive 
applications in heterocyclic chemistry,12 and a number of 
methods for the preparation of 1,2,4-triazoles using 
microwave irradiation have been reported.13 However, no 
data on microwave-based syntheses of 3(5)-amino-1,2,4-
triazoles are available. Since water is an excellent solvent 
for microwave-assisted reactions,14 and provided it is a 
suitable medium for cyclocondensation of 1 under 
conventional heating, we attempted to use it as a solvent in 
the microwave-initiated synthesis. Four regimes with fixed 
microwave irradiation power were applied using a CEM 
“Discover” apparatus and 100 W was found to be optimal 
microwave power for the cyclization of 1a (Table 2).15 
These conditions were then applied successfully for the 
preparation of other 3(5)-amino-5(3)-(het)aryl-1,2,4-
triazoles (2) (Table 3). We attempted to prepare 2a by 
heating 1a in ethanol using similar irradiation conditions. 
However, a longer reaction time (5 min) was required and 
the isolated yield was lower (86%).  
The structures of the compounds prepared and particularly 
their tautomerism were investigated using both NMR 
spectroscopy, which is considered to be the most 
informative and accurate method for solutions,16 and X-ray 
crystallography, which provides comprehensive structural 
information in solid state.16b,c  




Microwave power, W Reaction time, sec Yield, % 
50 420 94 
100 150 100 
150 120 88 
200 70 82 
 




Triazole R Reaction time, sec Yield, % 
2a Ph 150 100 
2b 4-MeC6H4 165 100 
2c 4-MeOC6H4 165 100 
2d 4-FC6H4 150 90 
2e 4-ClC6H4 180 100 
2f 2-furyl 165 100 
2g 2-thienyl 180 100 
2h 2-pyridyl 150 84 
2i 3-pyridyl 150 100 
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Triazole R 1H NMR signals of tautomeric forms A and B in DMSO-d6 (0.1 M), ppm KT -ΔG298,  
kJ mol-1 
3(5)-NH2 N(1)-H 
A B A B 
2a Ph 5.29 6.05 13.20 12.04 8.2 5.2 
2b 4-MeC6H4 5.25 6.01 13.09 11.96 6.1 4.4 
2c 4-MeOC6H4 5.21 5.99 12.99 11.90 5.0 4.0 
2d 4-FC6H4 5.31 6.04 13.18 12.05 14.2 6.6 
2e 4-ClC6H4 5.37 6.10 13.25 12.12 20.6 7.5 
2f 2-furyl 5.29 6.07 13.20 12.07 13.6 6.5 
2g 2-thienyl 5.34 6.09 13.16 12.02 22.9 7.8 
2h 2-pyridyl 5.33 6.08 13.45 12.23 1.6 1.2 
2i 3-pyridyl 5.42 6.18 13.41 12.22 25.2 8.0 
2j 4-pyridyl 5.48 6.22 13.64 12.35 30.1 8.4 
.
The 1,2,4-triazoles 2 were found to exist in amino forms; 
imino forms were disfavored according to literature data.17 
Of the three tautomeric forms theoretically possible due to 
annular tautomerism (Scheme 2), forms A and B were 
found to be present in the solutions of triazoles 2, while 
form C was not observed under the experimental 
conditions.  
The equilibrium between the tautomers was established 
rapidly and the compositions did not change with time. The 
identical spectra of the tautomeric system A-B were 
observed instantaneously on dissolving the samples and 










Figure 1. Correlation of -ΔG for the tautomeric equilibrium of 3-amino-5-
aryl- and 5-amino-3-aryl-1,2,4-triazoles with the Hammett constant (σ) of 
the R group.  
The NH and NH2 signals of tautomers A and B in the 
1H 
NMR spectra in DMSO were quite distinct allowing 
calculation of KT values (Table 4). 5-Amino-1,2,4-triazoles 
B were identified to be the predominant tautomers. The 
substituent showed significant effects on the equilibrium 
between tautomeric forms A and B. This effect was 
strongly dependent on the electronic properties of the 
substituents. It was found that the KT and ΔG298 values 
correlated well with the Hammett constant18 of the 
substituents on the phenyl ring of 2a-e: -ΔG298 = 
8.086σ + 5.265, R2 = 0.998 (Fig. 1). Therefore, the 
thermodynamic stability of form B in comparison with A 
increased together with the electron-withdrawing properties 
of the substituents. This relationship could also be extended 
to some heterocyclic, i.e. 3-pyridyl, 4-pyridyl and 2-thienyl 
substituents at C3(5) of the 1,2,4-triazole ring. However, 
experimental results for compounds 2f,h with 2-furyl and 
especially 2-pyridyl substituents at these positions were 
outside this correlation. At first glance, this observation 
could be attributed to possible intramolecular hydrogen 
bonding between N1-H and the nitrogen atom of the 
pyridyl and the oxygen atom of the furyl moieties in form 
A. The intramolecular hydrogen bonding N1-H…X (X = O, 
N) would prevent shifting of the tautomeric equilibrium 
towards “electronically” favored form B despite the strong 
electron-withdrawing effect of the heterocycles. However, 
this explanation became wide open to criticism by detail 
analysis of further experiments. The signals of N(1)-H in 
the 1H NMR spectra appeared at the same range and had 
similar line widths for all triazoles 2. Increasing the 
concentration of the samples from 0.1 to 1.0 M caused a 
~0.2 ppm downfield shift of the signals (particularly NH 
and NH2) in the 
1H NMR spectra without affecting KT. 
Heating the sample should disfavor systems stabilized by 
intramolecular hydrogen bonding and would shift the 
equilibrium to form B. However, no significant changes in 
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KT were observed for 2f,h at elevated temperatures, 
similarly to 2 without potential intramolecular hydrogen 
bonding. The signals of the tautomers A and B appeared 
clearly in NMR spectra in DMSO-d6 solution and coalesced 
only on heating (Fig. 2). Interestingly, addition of nonpolar 
CDCl3 to the DMSO-d6 solution of triazoles 2f,h did not 
strengthen the intramolecular hydrogen bonding as 
expected. In contrast, the rate of the tautomeric exchange 
became too fast to be observed on the NMR time-scale. 
Only one set of signals appeared in the NMR spectra when 
a mixture of DMSO-d6 and CDCl3 (1:1) was used as 
solvent for the experiment, as exemplified in Fig. 2. 
Therefore, the “anomalous” thermodynamic stability of 
tautomeric forms A for 2f,h as well as the effect of solvents 
on the rate of tautomeric exchange are still to be revealed.  
Unsymmetric 3,5-disubstituted 1,2,4-triazoles have been 
known to crystallized in the form of tautomer bearing an 
electron-acceptor substituent at position 3 and an electron-
donor substituent at position 5.19 Surprisingly, we found 
that the presence of forms A and B in the crystal was 
possible even for compounds bearing substituents with 
considerably different electronic properties. Thus, two 
compounds i.e. 5-amino-3-phenyl-1,2,4-triazole and 3-
amino-5-phenyl-1,2,4-triazole (2a) crystallized together in 
the same crystal (Fig. 3) despite the fact that the KT value 
for their equilibrium in DMSO-d6 solution was 8.2. 
Conversely, 2h with a KT in DMSO-d6 solution equal to 
1.6, crystallized solely as 5-amino-3-(pyridin-2-yl)-1,2,4-
triazole (form B) (Fig. 4). 
In conclusion, an efficient and environmentally friendly 
method for the preparation of 3(5)-amino-1,2,4-triazoles 
has been developed and some aspects of the tautomerism in 
these compounds has been described.  
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Figure 2. 1H NMR spectra of 3(5)-amino-5(3)-(pyridin-2-yl)-1,2,4-triazole (2h) 0.1 M solution in DMSO-d6, 27 °C (a); 50 °C (b); 100 °C (c); 150 °C (d); 














































































Figure 4. X-ray structure of 2h21 
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